144 ·Filed Jun 11, 2026

QURE

uniQure N.V.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago SEC0001973379-26-000229
Actionable Insight • Neutral

These are routine sell-to-cover transactions for tax obligations upon RSU vesting, not discretionary insider selling. The dollar amounts are immaterial relative to market cap. No bearish signal — monitor for any unplanned open-market sales in future Form 4 filings.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
QURE ▲ +65.69% at T+60d
NEUTRAL call ✓ call won +65.69% · α vs SPY +62.42% · entry $27.57 → $45.68
Entry anchored
Jun 11, 03:59 PM ET
via exchange tick
T+1d
+1.09%
call +1.09% · α -0.68%
$27.87
settled 4mo ago
T+5d
+67.90%
call +67.90% · α +67.23%
$46.29
settled 4mo ago
T+20d
+54.62%
call +54.62% · α +52.84%
$42.63
settled 3mo ago
T+60d
+65.69%
call +65.69% · α +62.42%
$45.68
settled 24d ago

Price Chart

Loading chart...

Executive Summary

Two uniQure directors, David D. Meek and Jack Kaye, each filed Form 144 notices on June 11, 2026, signaling intent to sell shares. Meek plans to sell 7,970 shares (~$53,938) and Kaye plans to sell 7,970 shares (~$53,938) plus an additional 2,645 shares (~$79,384) from a prior vesting, for a combined ~$187,260. The sales are tied to restricted stock unit vesting and settlement of equity awards, not discretionary insider conviction selling.

Key Facts

  • Two directors (David D. Meek and Jack Kaye) filed Form 144 on June 11, 2026
  • Meek intends to sell 7,970 ordinary shares (~$53,938)
  • Kaye intends to sell 7,970 ordinary shares (~$53,938) plus 2,645 shares (~$79,384) from a prior vesting
  • All sales are attributed to restricted stock unit vesting and settlement of equity awards
  • Combined proposed sale value is approximately $187,260
  • Market cap is $1.7B; proposed sales represent ~0.01% of market cap

Financial Impact

Combined ~$187,260 in proposed insider sales, representing ~0.01% of $1.7B market cap

dilutioninsider holdings

Risk Factors

  • If additional directors or executives file unexpected Form 144s in the coming weeks, it could signal broader insider sentiment shift
  • The stock has shown high volatility historically (T+20 moves >30% in prior reports), so even small signals can be amplified

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (QURE) — Batch item 10001973379-26-000229
Document: 0001973379-26-000229-index.html0001973379-26-000228
Document: 0001973379-26-000229.txt0001973379-26-000229
144 Filing (QURE) — Batch item 40001973379-26-000228
Document: 0001973379-26-000228-index.html0001973379-26-000229
Document: 0001973379-26-000228.txt0001973379-26-000229
32 reports for QURE
Performance horizon
67% Hit rate 6 of 9 directional calls best @ T+20▲ +27.15%Jul 29, 2026
Filters
Rows
Reports for QURE — sortable, filterable
TypeNow
Sep 2, 2026
4w ago
8-K
BULLISH ★ 7/10
$46.23 $44.47▼ −3.81%▼ −2.85%$23.46 (−49.25%)
Jul 29, 2026
9w ago
8-K
BULLISH ★ 8/10
$40.07 $44.24▲ +10.41%▲ +4.88%$23.46 (−41.45%)
Jul 7, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$41.41 $41.52▼ −0.27%▲ +0.29%$23.46 (+43.35%)
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 4/10
$41.81 $44.48▼ −6.39%▼ −5.46%$23.46 (+43.89%)
Jul 2, 2026
13w ago
Insider Cluster
MIXED ★ 5/10
$41.81 $44.48▲ +6.39%▲ +5.46%$23.46 (−43.89%)
Jul 2, 2026
13w ago
144
NEUTRAL ★ 2/10
$41.81 $44.48▲ +6.39%▲ +5.46%$23.46 (−43.89%)
Jun 30, 2026
13w ago
144
NEUTRAL ★ 2/10
$45.17 $41.41▼ −8.32%▼ −8.59%$23.46 (−48.06%)
Jun 25, 2026
14w ago
144
BEARISH ★ 5/10
$47.51 $41.81▲ +12.00%▲ +14.16%$23.46 (+50.62%)
Jun 24, 2026
14w ago
424B5
MIXED ★ 6/10
$49.10 $45.17▼ −8.00%▼ −9.56%$23.46 (−52.22%)
Jun 24, 2026
14w ago
144
NEUTRAL ★ 2/10
$49.10 $45.17▼ −8.00%▼ −9.56%$23.46 (−52.22%)
Showing 10 of 32

US Market Status

Market Closed — Opens Mon (64h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access